ATE21889T1 - Verfahren zur herstellung von fein zerteilter p- butoxyphenylacethydroxamsaeure und die sie enthaltenden zusammensetzungen. - Google Patents

Verfahren zur herstellung von fein zerteilter p- butoxyphenylacethydroxamsaeure und die sie enthaltenden zusammensetzungen.

Info

Publication number
ATE21889T1
ATE21889T1 AT83201719T AT83201719T ATE21889T1 AT E21889 T1 ATE21889 T1 AT E21889T1 AT 83201719 T AT83201719 T AT 83201719T AT 83201719 T AT83201719 T AT 83201719T AT E21889 T1 ATE21889 T1 AT E21889T1
Authority
AT
Austria
Prior art keywords
acid
preparation
butoxyphenylacethydroxamic
compositions containing
finely divided
Prior art date
Application number
AT83201719T
Other languages
English (en)
Inventor
Michel Franz
Andras Vincze
Georges Lambelin
Alain Polat
Original Assignee
Continental Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19730000&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE21889(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Continental Pharma filed Critical Continental Pharma
Application granted granted Critical
Publication of ATE21889T1 publication Critical patent/ATE21889T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT83201719T 1982-12-13 1983-12-05 Verfahren zur herstellung von fein zerteilter p- butoxyphenylacethydroxamsaeure und die sie enthaltenden zusammensetzungen. ATE21889T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
LU84530A LU84530A1 (fr) 1982-12-13 1982-12-13 Procede de preparation d'acide p-butoxyphenylacethydroxamique a l'etat finement divise et composition contenant cet acide
EP83201719A EP0116182B2 (de) 1982-12-13 1983-12-05 Verfahren zur Herstellung von fein zerteilter p-Butoxyphenylacethydroxamsäure

Publications (1)

Publication Number Publication Date
ATE21889T1 true ATE21889T1 (de) 1986-09-15

Family

ID=19730000

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83201719T ATE21889T1 (de) 1982-12-13 1983-12-05 Verfahren zur herstellung von fein zerteilter p- butoxyphenylacethydroxamsaeure und die sie enthaltenden zusammensetzungen.

Country Status (7)

Country Link
US (1) US4534911A (de)
EP (1) EP0116182B2 (de)
JP (1) JPS59110655A (de)
AT (1) ATE21889T1 (de)
CA (1) CA1218675A (de)
DE (1) DE3365914D1 (de)
LU (1) LU84530A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3468336D1 (en) * 1983-06-22 1988-02-11 Univ Ohio State Res Found Small particle formation
DE3604050A1 (de) * 1986-02-08 1987-08-13 Boehringer Mannheim Gmbh Thioether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
EP0885609A1 (de) * 1997-06-17 1998-12-23 Continental Pharma Incorporated Verwendung einer pharmazeutischen Zusammensetzung zur Behandlung traumatischer Arthritis in Pferden

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB921536A (en) * 1960-02-18 1963-03-20 Basf Ag Substituted n-hydroxyureas and a process for their manufacture
SU390074A1 (ru) * 1970-08-04 1973-07-11 Всесоюзный научно исследовательский , проектный институт механической обработки полезных ископаемых Способ получения алкилгидроксамовых
SU632690A1 (ru) * 1977-06-08 1978-11-15 Предприятие П/Я М-5245 Способ получени с7-с9-алкилгидроксамовых кислот
JPS5777646A (en) * 1980-10-31 1982-05-15 Kanto Kagaku Kk Preparation of hydroxamic acid

Also Published As

Publication number Publication date
LU84530A1 (fr) 1984-10-22
CA1218675A (en) 1987-03-03
EP0116182B2 (de) 1989-12-27
US4534911A (en) 1985-08-13
DE3365914D1 (en) 1986-10-09
EP0116182B1 (de) 1986-09-03
EP0116182A1 (de) 1984-08-22
JPS59110655A (ja) 1984-06-26
JPS6121618B2 (de) 1986-05-28

Similar Documents

Publication Publication Date Title
GB2122594B (en) Apparatus and process for the manufacture of sulphuric acid(
PT77616B (en) Process for preparing imidazolylalkylthien-2-yl-tetrahydropyri-dazines and of pharmaceutical compositions containing the same
ATA153875A (de) Verfahren zur herstellung neuer 2-tetrahydrofurfuryl-6,7-benzomorphane und deren saureadditionssalzen
AT334881B (de) Verfahren zur herstellung neuer 1-phenoxy-2-hydroxy-3-aminopropane und deren saureadditionssalze
DE3768720D1 (de) Verfahren zur trennung von aminosaeuren.
ATE21889T1 (de) Verfahren zur herstellung von fein zerteilter p- butoxyphenylacethydroxamsaeure und die sie enthaltenden zusammensetzungen.
AT350552B (de) Verfahren zur herstellung von neuen propargyl- 2-phenylamino-imidazolinen-(2) und deren saeureadditionssalzen
AT342019B (de) Verfahren zur herstellung von basischen cycloalkanonoximathern und deren saureadditionssalzen
ATE34747T1 (de) Verfahren zur herstellung von thiotetronsaeure.
DE69103913D1 (de) Verfahren zur Herstellung von Dodekandicarbonsäure.
ATE24723T1 (de) Neopentyl-phenethyltriazole, verfahren zu ihrer herstellung und diese enthaltende fungizide.
ATE59035T1 (de) Basisch substituierte benzofurancarbonsaeureamide, verfahren zu ihrer herstellung und sie enthaltende therapeutische mittel.
ATA195576A (de) Verfahren zur herstellung von neuen p-halogen-acylophenon- o - (2-aminoathyl)-oximathern und deren saureadditionssalzen
ATA328376A (de) Verfahren zur herstellung von neuen 3-aminomethyl-2-phenylbicyclo(2,2,2)octanen und deren saureadditionssalzen
AT376428B (de) Verfahren zur herstellung von neuen (3-alkylamino-2-hydroxypropoxy)-furan-2-carbons ureaniliden und deren physiologisch vertraeglichen saeureadditionssalzen
ATE11528T1 (de) Salze der cholsaeuren, verfahren zu ihrer herstellung und therapeutische zusammensetzungen, die sie als aktiven bestandteil enthalten.
ATE35985T1 (de) Ammoniumsalze von polysaeuren, verfahren zu ihrer herstellung, fungizide, die diese salze enthalten und verfahren zur bekaempfung von pilzen mit diesen salzen.
AT351020B (de) Verfahren zur herstellung neuer 4-phenyl- imidazoline und ihrer saeureadditionssalze
DE68925387D1 (de) Verfahren zur Behandlung von Immunotest-Proben, die Schleim enthalten
AT351030B (de) Verfahren zur herstellung von neuen 1,2- dihydro-6-phenyl-1h,4h-imidazo (1,2a) (1,4) benzodiazepin-1-onen sowie von deren saeure- additionssalzen
ATA140884A (de) Verfahren und vorrichtung zur herstellung einer organischen loesung einer in wasser unloeslichen organischen base
AT357545B (de) Verfahren zur herstellung neuer 5,5,7,7-tetra- methylfuro(3,4-e)as-triazine und ihrer saeure- additionssalze
ATE17713T1 (de) Verfahren zur herstellung von alphaarylalkans|uren.
JPS51111392A (en) Method and apparatus of removal of ammonia for amino acid analyser
ATE77363T1 (de) Verfahren zur herstellung von dichlorbernsteinsaeuredialkylestern.

Legal Events

Date Code Title Description
EELA Cancelled due to lapse of time